Medeiros L J, Lardelli P, Stetler-Stevenson M, Longo D L, Jaffe E S
Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Am J Clin Pathol. 1991 Apr;95(4):547-55. doi: 10.1093/ajcp/95.4.547.
Malignant lymphoma, diffuse, mixed small and large cell type, as defined in the Working Formulation, is heterogeneous both morphologically and immunophenotypically and, in some cases, clonality may be difficult to determine. Because gene rearrangement analysis has been shown to be a sensitive method for determining clonality, the authors genotyped 20 cases and compared the results with histologic and immunophenotypic findings. Immunophenotypic studies demonstrated that all lesions were composed predominantly of T cells. In addition, in eight cases either a monoclonal B-cell population (five lesions) or an aberrant immunophenotype (two T, one B) was detected, supporting a malignant diagnosis. In seven of these eight lymphomas, genotypic analysis confirmed the presence of a population of clonal cells. One case with an abnormal T-cell phenotype was germline. In 12 cases the immunophenotypic results were uncertain (i.e., no clonal population or abnormal immunophenotype was identified). Genotypic analysis provided evidence of clonality in eight. In four cases with uncertain immunophenotypic results, a clonal population also could not be identified with the use of Southern blot analysis. Thus, the authors conclude that gene rearrangement analysis is a valuable tool in the study of diffuse mixed cell lymphomas and is complementary to immunophenotypic studies. In addition, the authors analyzed the major breakpoint region of the bcl-2 protooncogene on chromosome 18, either by Southern blot analysis and/or with the polymerase chain reaction. The authors identified the t(14;18)(q32;q21) translocation in seven B-cell lymphomas, five of which were not considered to be of follicular center cell type on the basis of morphologic findings. These results suggest that the histologic spectrum of follicular center cell lymphomas is greater than is appreciated in the literature.
如工作分类法所定义,弥漫性混合小细胞和大细胞型恶性淋巴瘤在形态学和免疫表型上均具有异质性,在某些情况下,克隆性可能难以确定。由于基因重排分析已被证明是确定克隆性的一种敏感方法,作者对20例病例进行了基因分型,并将结果与组织学和免疫表型结果进行了比较。免疫表型研究表明,所有病变主要由T细胞组成。此外,在8例病例中检测到单克隆B细胞群体(5个病变)或异常免疫表型(2个T细胞,1个B细胞),支持恶性诊断。在这8例淋巴瘤中的7例中,基因分型证实存在克隆细胞群体。1例具有异常T细胞表型的病例为种系。在12例病例中,免疫表型结果不确定(即未鉴定出克隆群体或异常免疫表型)。基因分型在8例中提供了克隆性证据。在4例免疫表型结果不确定的病例中,使用Southern印迹分析也无法鉴定出克隆群体。因此,作者得出结论,基因重排分析是弥漫性混合细胞淋巴瘤研究中的一种有价值的工具,是免疫表型研究的补充。此外,作者通过Southern印迹分析和/或聚合酶链反应分析了18号染色体上bcl-2原癌基因的主要断裂点区域。作者在7例B细胞淋巴瘤中鉴定出t(14;18)(q32;q21)易位,其中5例根据形态学结果不被认为是滤泡中心细胞型。这些结果表明,滤泡中心细胞淋巴瘤的组织学谱比文献中所认识到的要广。